Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Abbott Next Generation Drug Eluting Stent 48mm Study

ClinicalTrials.gov ID: NCT04282148

Public ClinicalTrials.gov record NCT04282148. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 10:41 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Investigation to Assess the Abbott Next Generation Drug Eluting Stent 48mm Everolimus Eluting Coronary Stent System (EECSS) in Treatment of de Novo Native Coronary Artery Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions.

Study identification

NCT ID
NCT04282148
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
107 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2020 (Actual)
Primary completion
Oct 5, 2022 (Actual)
Completion
Sep 17, 2023 (Actual)
Last update posted
Jan 8, 2025

2020 – 2023

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
HonorHealth Scottsdale Arizona 85258 —
Scripps Memorial Hospital - La Jolla La Jolla California 92037 —
UCLA Medical Center Santa Monica Santa Monica California 90404 —
The Cardiac & Vascular Institute Research Foundation, LLC Gainesville Florida 32605 —
Shands at the University of Florida Gainesville Florida 32610 —
Via Christi Regional Medical Center - St. Francis Campus Wichita Kansas 67214 —
Cardiovascular Research Institute of Kansas Wichita Kansas 67226 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Minneapolis Heart Institute Minneapolis Minnesota 55407 —
North Mississippi Medical Center Tupelo Mississippi 38801 —
St. Patrick Hospital Missoula Montana 59802 —
Mount Sinai Hospital New York New York 10019 —
The Lindner Center Cincinnati Ohio 45219 —
St. Vincent Mercy Medical Center Toledo Ohio 43608 —
Pinnacle Health System Harrisburg Pennsylvania 17105 —
Greenville Health System Greenville South Carolina 29605 —
Baylor Scott & White Heart & Vascular Hospital Dallas Texas 75226 —
The Heart Hospital Baylor Plano Plano Texas 75093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04282148, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2025 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04282148 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →